2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases - Sorbonne Université Access content directly
Journal Articles Annals of the Rheumatic Diseases Year : 2022

2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

Annette de Thurah
Philipp Bosch
  • Function : Author
Andrea Marques
  • Function : Author
Yvette Meissner
Chetan Mukhtyar
Johannes Knitza
Aurélie Najm
Nina Østerås
Tim Pelle
  • Function : Author
Line Raunsbæk Knudsen
  • Function : Author
Hana Šmucrová
  • Function : Author
Francis Berenbaum
Meghna Jani
Rinie Geenen
  • Function : Author
Martin Krusche
Polina Pchelnikova
  • Function : Author
Savia de Souza
  • Function : Author
Sara Badreh
  • Function : Author
Dieter Wiek
  • Function : Author
Silvia Piantoni
James Gwinnutt
  • Function : Author
Christina Duftner
Helena Canhão
  • Function : Author
Luca Quartuccio
  • Function : Author
Nikolay Stoilov
  • Function : Author
Yeliz Prior
Johannes Wj Bijlsma
Alen Zabotti
Tanja Stamm
Christian Dejaco


Background Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring. However, guidance is needed on the integration of telehealth into clinical care of people with rheumatic and musculoskeletal diseases (RMD). Objective To develop EULAR points to consider (PtC) for the development, prioritisation and implementation of telehealth for people with RMD. Methods A multidisciplinary EULAR task force (TF) of 30 members from 14 European countries was established, and the EULAR standardised operating procedures for development of PtC were followed. A systematic literature review was conducted to support the TF in formulating the PtC. The level of agreement among the TF was established by anonymous online voting. Results Four overarching principles and nine PtC were formulated. The use of telehealth should be tailored to patient’s needs and preferences. The healthcare team should have adequate equipment and training and have telecommunication skills. Telehealth can be used in screening for RMD as preassessment in the referral process, for disease monitoring and regulation of medication dosages and in some non-pharmacological interventions. People with RMD should be offered training in using telehealth, and barriers should be resolved whenever possible. The level of agreement to each statement ranged from 8.5 to 9.8/10. Conclusion The PtC have identified areas where telehealth could improve quality of care and increase healthcare access. Knowing about drivers and barriers of telehealth is a prerequisite to successfully establish remote care approaches in rheumatologic clinical practice.

Dates and versions

hal-03994835 , version 1 (17-02-2023)



Annette de Thurah, Philipp Bosch, Andrea Marques, Yvette Meissner, Chetan Mukhtyar, et al.. 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. Annals of the Rheumatic Diseases, 2022, 81 (8), pp.1065-1071. ⟨10.1136/annrheumdis-2022-222341⟩. ⟨hal-03994835⟩
24 View
0 Download



Gmail Mastodon Facebook X LinkedIn More